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Abstract
Light emitting diodes (LED), which are available as small monochromatic light sources with
characteristic features such as maximum illumination power combined with minimum energy
consumption and extremely long lifespan have already proved as a highly potential low-cost
alternative for specific diagnostic applications in clinical medicine such as tuberculosis fluorescence
microscopy. Likewise, the most reliable evaluation of Her-2/neu (c-erbB2) gene amplification,
which has been established in the last few years for routine diagnosis in clinical pathology as
determinant towards Herceptin-based treatment of patients with breast cancer, is based on
fluorescence in situ hybridization (FISH) and corresponding high priced fluorescence equipment. In
order to test the possibility to utilize the advantages of low-cost LED technology on FISH analysis
of c-erbB2 gene expression for routine diagnostic purposes, the applicability of a standard bright
field Carl Zeiss Axiostar Plus microscope equipped with a Fraen AFTER* LED Fluorescence
Microscope Kit for the detection of Her-2/neu gene signals was compared to an advanced Nikon
Eclipse 80i fluorescence microscope in combination with a conventional 100W mercury vapor
lamp. Both microscopes were fitted with the same Quicam FAST CCD digital camera to
unequivocally compare the quality of the captured images. C-erbB2 gene expression was analyzed
in 30 different human tissue samples of primary invasive breast cancer, following formalin fixation
and subsequent paraffin-embedding. The Her2/neu gene signals (green) were identifiable in the
tumor cells in all cases and images of equal quality were captured under almost identical conditions
by 480 nm (blue) LED module equipped standard Axiostar microscope as compared to
conventional fluorescence microscopy. In this first attempt, these monochromatic LED elements
proved in principle to be suitable for the detection of Her-2/neu gene expression by FISH. Thus,
our own experiences emphasize the high potential of this technology to provide a serious
alternative to conventional fluorescence microscopy in routine pathology; representing a
sustainable technological progress, this low-cost technology will clearly give direction also to the
growing field of molecular pathology.
* AFTER = Amplified Fluorescence by transmitted Excitation of Radiation
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Findings
Light Emitting Diodes (LED) are characterized by low
cost, effective energy consumption and extremely long
lifespan when compared to conventional light sources [1].
Both the small size and the lack of heat development by
LED elements also contribute to these major advantages
above conventional lighting technology that altogether
imply considerable economic cost reductions. As a conse-
quence, there has been a fast propagation of LED elements
as important constituents in many different branches such
as automobile industry, household or camping [2,3].
More recently, the availability of a variety of small mono-
chromatic LED modules efficiently emitting the spectrum
in a single desired bandwidth has stimulated the interest
of clinical researchers to utilize this low-cost technology
for advanced fluorescence microscopy in diagnostic
research [4]. Since LED based light sources operate with-
out increasing their temperature, common safety prob-
lems related to considerable heat production by
conventional high pressure mercury lamps are completely
avoided. Most recently, LED modules attached to stand-
ard light microscopes have been successfully applied in
fluorescence-based screening of tuberculosis, pointing to
the considerable reduction of related costs combined with
increased safety and, as a consequence, to the potential for
low-income countries to perform such advanced diagnos-
tics of this disease in the near future [5,6]. Likewise, the
increasing application of highly sensitive but also expen-
sive molecular methods in clinical pathology such as the
analysis of altered gene expression patterns for cancer
diagnosis, has led to a general demand for reducing costs
in routine processes. In the last few years, the evaluation
of Her-2/neu status has considerably gained clinical
importance related to the selection of patients with breast
cancer, who will benefit most from a novel targeted ther-
apy based on Herceptin, a humanized monoclonal anti-
body directed against this protein [7,8]. Thus,
overexpression of Her-2/neu protein represents one of
only few available predictive markers for an individual-
ized and more efficient treatment regimen in this type of
cancer [9]. Since the enhancement of protein levels is pri-
marily correlated to the amplification of the correspond-
ing gene c-erbB2, fluorescence in situ hybridization (FISH)
has been established for the determination of Her-2/neu
gene. FISH is characterized by excellent sensitivity
(96.5%) and specificity (100%) [10]. Thus, this diagnostic
assay has been introduced in routine clinical pathology,
despite the considerable costs involving expensive rea-
gents and the need to purchase high priced fluorescent
equipment before deciding the further steps in the compa-
rably much more expensive treatment with all its possible
therapeutic side effects.
For this reason, the use of small monochromatic LED
modules as the required light source for routinely per-
formed FISH analysis of Her-2/neu status appeared to us
as a promising alternative to eventually replace the short-
lived and expensive conventional mercury vapor lamp.
For this purpose, a commercially available AFTER (Ampli-
fied Fluorescence by transmitted Excitation of Radiation)
LED Fluorescence Microscope Kit (Lab Vision, Fremont,
USA) was mounted to a standard Zeiss Axiostar Plus trans-
mitted light microscope (Medac, Wedel, Germany), pro-
viding a simple adaptation of a fluorescence microscope.
Determination of ZyGreen c-erb-B2 gene was performed
by attaching a 480 nm Fraen fluorescence light cassette to
the Axiostar Plus in combination with a LP 510 nm long
pass filter. For comparison reasons, the Zeiss microscope
was also fitted with a Quicam FAST CCD digital camera,
which is normally attached to the Nikon Eclipse 80i fluo-
rescence microscope for routine determination of cerb-B2
gene amplification. Her-2/neu gene expression was docu-
mented at 400× magnification. A total of 30 tissue sam-
ples from patients with primary invasive breast carcinoma
were analyzed by FISH. After mastectomy, the specimens
were fixed by formalin and subsequently paraffin-embed-
ded. Optimal comparability among all samples was
achieved by producing a tissue micro array (TMA), as pre-
viously described [11]. FISH was performed, using Zyto-
Light Spec Her-2 Color Probe (ZytoVision GmbH,
Bremerhaven, Germany). Briefly, a 4 μm thick section of
the TMA was deparaffinized with xylene, dehydrated and
pre-treated with enzyme and heat, according to the man-
ufacturer's instructions. After addition of 10 μl SPEC
HER2 Color probe, denaturation was carried out at 75°C
for 10 min, followed by hybridization overnight at 37°C.
Post hybridization washing, subsequent dehydration in
ethanol and counterstaining with DAPI (4,6-diaminido-
2-phenylindole dihydrochloride)/antifade-solution was
performed, as specified. The slides were kept in the dark at
4°C until evaluation.
The age of the patients ranged between 44 years and 84
years (median age 61 y) with 77% of the women being in
the postmenopausal phase. The majority of the breast
cancer tissues (86%) were related histologically to the
invasive ductal type of tumor. Amplification of cerb-B2
gene was detected by FISH in 36% of the specimens.
Brightness of the Her-2/neu gene signals was always suffi-
cient using the LED equipped Axiostar Plus microscope
and corresponding photographs of high quality were cap-
tured by extended integration times between 3 and 10 sec-
onds.
To our knowledge, this is the first attempt to use LED
modules instead of a 100 W mercury vapor lamp as light
source to perform FISH analysis of clinically relevant Her-
2/neu gene expression for routine pathology. Up to date,
the introduction of LED technology in diagnostic research
has been very successful as recently demonstrated for theDiagnostic Pathology 2008, 3:49 http://www.diagnosticpathology.org/content/3/1/49
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fluorescence based screening of tuberculosis [5,6,12].
Likewise, in our studies the standard light transmission
microscope Axiostar Plus became suitable for FISH analy-
sis by simply attaching a commercially available adapta-
tion kit for fluorescence microscopy. The appropriate
combination of a particular LED module and the corre-
sponding long pass emission filter was sufficient to
replace the advanced Nikon fluorescence microscope.
Moreover, the lack of heat production by the LED light
sources completely avoided common safety problems
related to conventional mercury vapor lamps. The exten-
sion of the integration time was the only major modifica-
tion of the otherwise identical conditions to capture
pictures of equal quality as compared to the routinely
used high priced fluorescence equipment. Integration
times less than 3 times shorter to be sufficient for docu-
mentation, as demonstrated for the 100 W mercury lamp,
still emphasize the need for LED modules with further
increased illumination power. Moreover, the develop-
ment of LED light sources with corresponding long pass
emission filters that are suitable for the detection of ZyOr-
ange labeled probes would enable the combined analysis
of both cerb-B2 gene and corresponding chromosome 17
as the most reliable determination of the Her-2/neu status
Detection of Her-2/neu gene expression in human breast cancer tissue by FISH analysis Figure 1
Detection of Her-2/neu gene expression in human breast cancer tissue by FISH analysis. Two exemplary tissues of 
breast cancer exhibiting no amplification (A, B) or strong amplification of Her-2/neu gene (C, D) are shown (400× magnifica-
tion). ZyGreen labeled Her-2/neu gene signals captured by advanced Nikon fluorescent microscope in combination with con-
ventional 100W mercury vapor lamp (A, C) are directly compared with those captured by standard bright field Carl Zeiss 
Axiostar Plus microscope equipped with a Fraen AFTER LED Fluorescence Microscope Kit (B, D). Cerb-B2 gene expression 
was detected by a 480 nm Fluorescence light cassette combined with a 510 nm long pass emission filter mounted to the Axios-
tar microscope. Equal quality of the captured pictures was achieved by integration times between 1 and 3 seconds (A, C, 100W 
mercury vapor) and 6 and 10 seconds (B, D, LED).Publish with BioMed Central    and   every 
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in patients with breast cancer. In addition, the possibility
to simply switch between different LED modules instead
of the necessity to exchange the whole elements would
considerably simplify the applicability of LED elements,
since fluorescence based assays such as FISH using com-
mercially available dual color labeled kits are increasingly
introduced into clinical research. In summary, although
there is still need for some further developments, our own
experiences emphasize the high potential of these mono-
chromatic LED elements with all their characteristic fea-
tures to provide a serious alternative to conventional
advanced fluorescence microscopy in routine pathology.
Without dispute this low-cost technology has initiated a
sustainable technological progress giving direction also to
the growing field of molecular pathology.
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